Given the differences in the human tau species expressed in these two mouse models, the overexpression of two different forms of tau can lead to two very distinct and robust phenotypes that show characteristic features of Alzheimer’s disease-like and FTLD-like tauopathies. Here, MAPT is linked to early-onset autosomal dominant Alzheimer disease.